Stem Cells Translational Medicine · 2022 · 14 citations · 42 references
Life SciencesNeurobiologyNeuroscienceCell SignalingCell TherapyMolecular NeuroscienceIntegrin SignalingNeural RegenerationNeurodegenerative DiseasesNeurodegenerative DisordersParkinson DiseaseParkinsonian DisordersDopaminergic NeurodegenerationDopaminergic NeuronsIntegrin BindingIntegrin-ligand BindingNigrostriatal Dopamine SystemParkinson’s Disease TreatmentRas SignalingRas Signaling Activation
The therapeutic effect of a cell replacement therapy for Parkinson's disease (PD) depends on the proper maturation of grafted dopaminergic (DA) neurons and their functional innervation in the host brain. In the brain, laminin, an extracellular matrix protein, regulates signaling pathways for the survival and development of neurons by interacting with integrins. The heparan sulfate (HS) chain binds mildly to various neurotrophic factors and regulates their intracellular signaling. Perlecan-conjugated laminin 511/521-E8 fragments (p511/p521) were designed to contain an integrin-binding site and HS chains. Here we examined the effect of treating DA progenitors with p511/p521 prior to transplantation in rodent PD models. In vitro and in vivo experiments showed that p511/p521 treatment enhanced the maturation and neurite extension of the grafted DA progenitors by activating RAS-ERK1/2 signaling. This strategy will contribute to an efficient cell replacement therapy for PD in the future.
42
Sonja Kriks, Jaewon Shim, Jinghua Piao et al. · Nature · 2011 · 1.9K citations
Human iPS cell-derived dopaminergic neurons function in a primate Parkinson’s disease model
Tetsuhiro Kikuchi, Asuka Morizane, Daisuke Doi et al. · Nature · 2017 · 693 citations
Bente Pakkenberg, H.J.G. Gundersen, Agnete Mouritzen Dam et al. · Journal of Neurology Neurosurgery & Psychiatry · 1991 · 404 citations · Full text
Medicine, Neurobiology, Neuroscience +11
Junichi Takagi, Maria Hayashi, Hiroyuki Ido et al. · Matrix Biology · 2006 · 385 citations